Biotech stocks have fallen to earth with a thud in 2021 after soaring last year amid excitement over the development of Covid-19 vaccines, dealing big losses to some hedge funds.
The sector is being buffeted by concerns Congress will move to put a lid on drug pricing and a surfeit of early-stage biotech shares as the IPO market booms.
San Bernardino County sheriff’s investigators on Sunday, Aug. 17, searched the house of the mother and father of the infant…
Studying Time: 2 minutes It's sadly over for one more actuality tv…
Studying Time: 3 minutes Meri Brown seems to be going via it…
Federal Reserve Chair Jerome Powell explains how policymakers will work…
